» Articles » PMID: 17431723

A Meta-analysis of Quality of Life for Abdominoperineal Excision of Rectum Versus Anterior Resection for Rectal Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2007 Apr 14
PMID 17431723
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Avoiding a permanent stoma following rectal cancer excision is believed to improve quality of life (QoL), but evidence from comparative studies is contradictory. The aim of this study was to compare QoL following abdominoperineal excision of rectum (APER) with that after anterior resection (AR) in patients with rectal cancer.

Methods: A literature search was performed to identify studies published between 1966 and 2006 comparing values of QoL following APER and AR. Random-effect meta-analysis was used to combine the data. Sensitivity analyses were performed for larger studies, those of higher quality and those using self-administered QoL questionnaires.

Results: The outcomes for 1,443 patients from 11 studies, of whom 486 (33%) underwent APER, were included. QoL assessments were made at periods of up to 2 years following surgery. There was no significant difference in global health scores between APER and AR. Vitality (WMD -9.82; 95% CI -27.01, -2.04, P = 0.01) and sexual function (WMD -2.73; 95% CI -4.93, -0.64, P = 0.01) were improved in the AR patients. Patients with low AR had improved physical function scores in comparison with APER patients (WMD -4.67; 95% CI -9.10, -0.23; P = 0.004). Cognitive (WMD 3.57; 95% CI 1.41, 5.73; P < 0.001) and emotional function scores (WMD 3.51; 95% CI 1.40, 5.62; P < 0.001) were higher for APER patients.

Conclusion: Overall, when comparing APER with AR, we identified no differences in general QoL following the procedures. Individualisation of care for rectal cancer patients is essential, but a policy of avoidance of APER cannot currently be justified on the grounds of QoL alone.

Citing Articles

Preferences for treatment outcomes in rectal cancer: A discrete choice experiment among patients and healthy volunteers.

Miles A, Steele R, Hutton G, Morris S Colorectal Dis. 2025; 27(2):e70021.

PMID: 39924856 PMC: 11808228. DOI: 10.1111/codi.70021.


Total neoadjuvant therapy followed by total mesorectal excision for rectal cancer in older patients real world data and proof of concept.

Montroni I, Di Candido F, Taffurelli G, Tamberi S, Grassi E, Corbelli J Front Surg. 2024; 11:1448073.

PMID: 39628921 PMC: 11611805. DOI: 10.3389/fsurg.2024.1448073.


The effect of telemedicine on stoma-related complications in adults with enterostomy: A systematic review and meta-analysis.

Wei-Ying Z, Hui-Ren Z, Hai-Ping Y, Li-Li M Int Wound J. 2024; 21(1):e14572.

PMID: 38272790 PMC: 10789586. DOI: 10.1111/iwj.14572.


Major low anterior resection syndrome has equivalent health-related quality of life implications as having a permanent colostomy.

Koneru S, Builth-Snoad L, Rickard M, Keshava A, Chapuis P, Ng K Tech Coloproctol. 2023; 28(1):17.

PMID: 38099961 DOI: 10.1007/s10151-023-02879-y.


Effect of melatonin in patients with low anterior resection syndrome (MELLARS): a study protocol for a randomised, placebo-controlled, crossover trial.

Zahid J, Madsen M, Bulut O, Christensen P, Gogenur I BMJ Open. 2023; 13(9):e067763.

PMID: 37696629 PMC: 10496695. DOI: 10.1136/bmjopen-2022-067763.